Concepedia

Eyas Abu-Raddad

EA

Statistics

Publications

4

Citations

334

H-Index

4

Active since

2005

Affiliations

Eli Lilly (United States)(Current)

Istituto di Analisi dei Sistemi ed Informatica Antonio Ruberti

Eyas Abu-Raddad is an author at Eli Lilly (United States) specializing in diabetes mellitus, insulin resistance, and medicine.

Publications per year

2005–2013

4

Publications

4

Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes

Joanne Sloan‐Lancaster, Eyas Abu-Raddad, John Polzer et al. · Diabetes Care · 2013 · 180 citations · Full text

, , +17

Mathematical models of diabetes progression

Andrea De Gaetano, Thomas A. Hardy, Benoît Beck et al. · American Journal of Physiology-Endocrinology and Metabolism · 2008 · 113 citations

, , +17

Evaluation of a mathematical model of diabetes progression against observations in the Diabetes Prevention Program

Thomas A. Hardy, Eyas Abu-Raddad, Niels Pörksen et al. · American Journal of Physiology-Endocrinology and Metabolism · 2012 · 30 citations

, , +16

Clinical Pharmacokinetics of Alamifovir and Its Metabolites

Clark Chan, Eyas Abu-Raddad, Georg Golor et al. · Antimicrobial Agents and Chemotherapy · 2005 · 11 citations · Full text

, , +14

1–4 of 4